| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +34% |
| 3Y CAGR | +9% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +394% |
| 3Y CAGR | +35% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,222.00 -27.10 (1.20%) | 17,105.67 | 25.23 | 5.08 | ||
PfizerPFIZER | ₹3,612.30 -76.60 (2.08%) | 16,879.31 | 22.96 | 4.02 | ||
Natco PharmaNATCOPHARM | ₹791.85 +6.70 (0.85%) | 15,408.99 | 13.46 | 1.47 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹5,988.50 -112.50 (1.84%) | 15,246.63 | 89.88 | 17.47 |